One Health & Zoonoses

BRIN and IAEA Expand Zoonotic Surveillance Across 18 Countries

BRIN and the IAEA have joined forces to strengthen zoonotic disease surveillance across 18 countries, aiming for faster detection of pathogens moving between animals and humans.

Updated

Indonesia's National Research and Innovation Agency (BRIN) is working with the International Atomic Energy Agency (IAEA) to strengthen zoonotic disease surveillance across 18 countries, an arrangement that widens the laboratory network veterinarians in participating nations can draw on when unusual fevers, abortions, or die-offs appear in livestock or companion animals.

The partnership links BRIN to an IAEA-coordinated surveillance framework spanning 18 countries. For practitioners, the practical consequence is earlier detection: zoonotic pathogens such as those causing avian influenza, leptospirosis, and other emerging infections move first through animal populations, and coordinated surveillance shortens the gap between the first suspicious case and the laboratory confirmation that triggers response.

What does the partnership change?

The IAEA supports veterinary laboratories through nuclear and nuclear-derived diagnostic techniques, including polymerase chain reaction (PCR) and related molecular tools that identify pathogens faster than conventional culture methods. By folding BRIN's laboratories into this 18-country framework, the arrangement aims to standardize detection methods and speed the exchange of surveillance data across borders.

For food-animal veterinarians, that coordination matters most at the herd level. Poultry and swine operations sit at the front line of several zoonotic threats, and cross-border surveillance networks can flag regional spread before outbreaks reach national borders. For companion-animal practitioners, the public-health dimension is quieter but real: several pathogens that circulate in wildlife and livestock also infect dogs and cats, and surveillance data shapes post-exposure guidance and vaccination decisions.

Why the IAEA is involved in animal health?

The IAEA's role in zoonotic surveillance runs through its technical cooperation programs, which equip laboratories in member states with molecular diagnostic platforms and train staff to run them. The agency's framework emphasizes early detection of pathogens with pandemic potential — a mandate that gained urgency after COVID-19 and after highly pathogenic avian influenza spread across multiple regions in recent years.

BRIN, as Indonesia's umbrella research body, contributes laboratory capacity in a country that ranks among the world's most biodiverse and has historically been an origin point for emerging infectious diseases. Indonesia's archipelagic geography adds surveillance complexity: animal movement between thousands of islands creates pathways for pathogen spread that national monitoring alone struggles to track.

What does this mean at the exam table and in the barn?

Public-health implications anchor the program. Zoonotic diseases — those transmitted between animals and humans — account for a substantial share of emerging infectious events globally, and most originate in animal reservoirs. Surveillance networks of this kind exist to shorten detection times.

For veterinary practice in participating countries, the changes arrive indirectly:

  • Faster laboratory confirmation of suspected zoonotic infections, which supports earlier client communication and reporting
  • Stronger data on regional pathogen movement, informing biosecurity recommendations for farms and clinics
  • A broader evidence base for guidance on species that bridge animal and human infection

What comes next?

The partnership positions the 18-country network to expand pathogen coverage and diagnostic throughput as BRIN and IAEA deepen cooperation, and veterinarians in participating states should watch for surveillance outputs that sharpen regional risk assessments in the seasons ahead.

By Nathan Brooks

Source: Google News: Zoonotic disease

Share this article:

Nathan Brooks

Show full bio

Senior reporter covering companies, deals and strategy in Small- and large-animal clinical practice at The Vet Scope.

More from Nathan Brooks →